[Major alpha-thalassemia: antenatal diagnosis, case report and literature review]

H Saadi1, S Alexander, P Barlow

  • 1Service de gynécologie-obstétrique, CHU Hassan-II, Fès, Maroc.

Insights

Homozygous alpha-thalassaemia, or Bart's hydrops fetalis, is a lethal fetal genetic condition. Early diagnosis via ultrasound and genetic testing is crucial for managing maternal risks like preeclampsia.

Area of Science:

  • Medical Genetics
  • Fetal Medicine
  • Obstetrics

Background:

  • Homozygous alpha-thalassaemia (Bart's hydrops fetalis) is a severe autosomal recessive genetic disorder.
  • It leads to fetal lethality due to severe anemia and hypoxia.
  • Maternal complications include an increased risk of severe preeclampsia.

Observation:

  • Diagnosis is suspected with suggestive ultrasonographic findings in fetuses of parents from South-East Asia or China.
  • A rare case presented with fetal growth retardation, cardiomegaly, and enlarged placenta at 26 weeks gestation.
  • Molecular genetic analysis confirms alpha globin gene deletions or mutations.

Findings:

  • The case highlights the importance of recognizing Bart's hydrops fetalis through specific fetal anomalies.
  • Molecular confirmation relies on identifying characteristic alpha globin gene alterations.
  • This condition poses significant risks to both the fetus and the mother.

Implications:

  • Increased awareness and inclusion of alpha thalassemias in medical and midwifery curricula are essential.
  • Early diagnosis can guide management strategies and improve maternal outcomes.
  • Genetic counseling and screening are vital for at-risk populations.